Importantly, our large patient population allows us to confidently rule out a link between CD34 staining and hepatocyte ballooning or steatosis, suggesting that drivers for LSEC capillarisation might not be derived from hepatocytes but possibly rather from circulating cells or mediators present in the portal blood in the context of metabolic syndrome. This evidence concerns the gene CD34 and metabolic syndrome.